Testing a new continuous glucose monitor
Part of Hormones & metabolism clinical trials.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have type 1 or type 2 diabetes.
- You can have a blood draw from your forearm.
- You are willing to follow the study instructions and sign a consent form.
- You should not have had severe low blood sugar in the last 6 months.
- The skin where the sensor goes should be healthy and free of rashes or sores.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new continuous glucose monitor that checks blood sugar levels without frequent finger pricks. It aims to see how accurate and safe it is for people with type 1 diabetes.
This trial tests a new device that measures blood sugar and ketones continuously. It may help people with type 1 diabetes who use an insulin pump keep better track of their levels.
This study looks at how people with diabetes feel about using a continuous glucose monitor (CGM) and their blood sugar readings. It aims to learn what works best for patients and healthcare providers to improve diabetes care.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
This study tests a new sensor system that tracks glucose levels continuously and can give a quick reading when you wave a device over it. It aims to see if it's safe and accurate for people with diabetes.
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
Hear when a new Type1diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.